<DOC>
	<DOCNO>NCT01169389</DOCNO>
	<brief_summary>This study aim investigate analgesic effect offer bupivacaine Durolane ( hyaluronic acid supplement ) administer immediately follow completion knee arthroscopy .</brief_summary>
	<brief_title>Analgesic Control Following Knee Arthroscopy</brief_title>
	<detailed_description>There increase evidence toxic effect intraarticular administration local anaesthetic . Hyaluronic acid supplementation give time knee arthroscopy fully evaluate possible alternative . We study efficacy hyaluronic acid ( HA ) supplement ( Durolane® ) local anaesthetic ( Bupivacaine ) provide early short-term post-operative analgesic control follow knee arthroscopy.Patients randomise receive either 10mls 0.5 % Bupivacaine 10mls Durolane® joint immediately completion surgery . WOMAC Tegner-Lysholm score obtain baseline 1 , 2 , 6-weeks post surgery . VAS pain score obtain baseline ; 1 24-hours ; 1 , 2 6 week follow surgery .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>undergo knee arthroscopy : diagnostic purpose , removal loose body , articular cartilage debridement , meniscectomy age 18 year American Society Anaesthesiologists ( ASA ) grade ≥3 ; arthroscopic assist osteotomy ; history two prior procedure ipsilateral knee ; postoperative morbidity indirectly link procedure ( e.g . anaesthetic complication , DVT PE ) ; systemic steroid requirement ; previous intraarticular anaesthetic steroid injection within last three month ; intraarticular HA injection within last nine month ; intraarticular sepsis within previous three month ; prior history knee arthroplasty , periarticular fracture , ligamentous instability , inflammatory arthritis previous diagnosis Complex Regional Pain Syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>